This trial is active, not recruiting.

Condition obesity
Sponsor Huashan Hospital
Start date October 2010
End date December 2013
Trial size 30 participants
Trial identifier NCT01387451, KY2010-115


Retrospective studies have combined positron-emission tomography and computed tomography (PET-CT) to identify adipose tissue with a high rate of uptake of 18F-fluorodeoxyglucose(18F-FDG) as active brown adipose tissue(BAT). In addition, biopsy specimens and immunohistochemical staining with a UCP1-specific antiserum were used to indicate that normal adults were able to have BAT. However,these studies only chose few subjects and limited to the neck tissue. Therefore, the investigators intend to test BAT in different parts of adults and analyse the clinical factors.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model case-only
Time perspective cross-sectional

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Subjects who underwent surgical therapy and the operation scope includes BAT sample sites. Exclusion Criteria: - Pregnant women - With implantable medical electronic instrument - Younger than 18 years

Additional Information

Official title Cross Sectional Study on the Detection and Factors of Brown Adipose Tissue in Different Locations of Adults
Description The investigators will promote the cross-sectional study from 2010 to 2013 in Shanghai. Data on demographic statistics, medical history,physical examination and fasting blood sample will be collected for all patients. Adipose tissue of adults will be collected from different regions, such as cervical, perirenal, along the large blood vessels and trachea, because they are included in the range of surgical therapy and are the major locations of BAT. Adipose tissue samples will be used to immunohistochemical stain, to detect the expression of BAT related genes.
Trial information was received from ClinicalTrials.gov and was last updated in July 2011.
Information provided to ClinicalTrials.gov by Huashan Hospital.